Ephedrine Sulfate Injection
Product Images NDC 70069-819

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ephedrine Sulfate (NDC 70069-819). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (320a0a1f 18e3 4bdb 8856 965f403666ba 01)

Chemical structure of Ephedrine Sulfate depicted as two ephedrine molecules associated with a sulfuric acid (H2SO4) molecule, representing its sulfate salt form.*

FDA Label Image

Image (320a0a1f 18e3 4bdb 8856 965f403666ba 02)

Label for Ephedrine Sulfate Injection, USP 50 mg/mL single-dose vial. The label indicates it must be diluted for intravenous use. Manufactured by Gland Pharma Limited, India, and distributed by Somerset Therapeutics, LLC, Somerset, NJ. Includes NDC 70069-819-01 and barcode. Expiration and lot number fields are present but not visible.*

FDA Label Image

Image (320a0a1f 18e3 4bdb 8856 965f403666ba 03)

Carton label for Ephedrine Sulfate Injection, USP 50 mg/mL by Somerset Therapeutics, LLC. It contains 10 single-dose vials, 1 mL each, for intravenous use. The label indicates the product must be diluted before administration and provides the NDC 70069-819-10. Manufacturing and distribution information is also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.